Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Anna Glantz is a leading researcher in maternal-fetal medicine, with a primary focus on the genetic and clinical underpinnings of intrahepatic cholestasis of pregnancy (ICP). Her major contributions center on unraveling the complex genetic architecture of this condition, demonstrating that ICP arises from a combination of rare heterozygous mutations in canalicular transporters and common population susceptibility alleles. Her landmark 2013 study, cited over 120 times, provided a comprehensive analysis of genetic variation around six candidate loci, significantly advancing our understanding of how genetic predisposition interacts with environmental factors to trigger ICP. This work has been instrumental in identifying at-risk populations and informing clinical management strategies. Dr. Glantz’s research has not only deepened the scientific community’s grasp of ICP’s etiology but has also paved the way for improved screening and personalized care for pregnant individuals. Her findings continue to shape guidelines for monitoring and treatment, making her a pivotal figure in the field of obstetric genetics.